| Breakdown | TTM | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 550.00M | 454.00M | 575.00M | 418.00M | 412.00M | 520.00M |
| Gross Profit | 417.00M | 331.00M | 429.00M | 321.00M | 279.00M | 340.00M |
| EBITDA | 313.00M | 454.00M | 122.00M | -944.00M | 1.05B | 270.00M |
| Net Income | 447.00M | 338.00M | -1.00M | -1.04B | 963.00M | -1.03B |
Balance Sheet | ||||||
| Total Assets | 8.99B | 8.88B | 7.97B | 8.29B | 9.91B | 8.88B |
| Cash, Cash Equivalents and Short-Term Investments | 86.00M | 57.00M | 88.00M | 125.00M | 111.00M | 154.00M |
| Total Debt | 2.77B | 2.84B | 2.34B | 2.39B | 2.75B | 2.54B |
| Total Liabilities | 3.17B | 3.17B | 2.66B | 2.77B | 3.14B | 2.89B |
| Stockholders Equity | 5.82B | 5.71B | 5.30B | 5.51B | 6.75B | 5.92B |
Cash Flow | ||||||
| Free Cash Flow | 130.00M | 54.00M | 97.00M | 31.00M | -14.00M | -23.00M |
| Operating Cash Flow | 302.00M | 270.00M | 409.00M | 240.00M | 245.00M | 149.00M |
| Investing Cash Flow | -519.00M | -853.00M | -172.00M | 326.00M | -423.00M | 910.00M |
| Financing Cash Flow | 215.00M | 552.00M | -274.00M | -552.00M | 98.00M | -1.10B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
80 Outperform | £4.47B | 7.70 | 7.16% | 6.67% | 43.70% | 40.28% | |
75 Outperform | £3.80B | 3.98 | 7.75% | 5.85% | -20.83% | ― | |
73 Outperform | £4.31B | 11.16 | 3.85% | 6.34% | 10.69% | 135.58% | |
72 Outperform | £431.41M | 3.34 | 11.57% | 7.17% | 1.60% | 211.81% | |
71 Outperform | £170.42M | 9.16 | 7.33% | 7.43% | -10.95% | -30.09% | |
65 Neutral | $2.17B | 12.19 | 3.79% | 4.94% | 3.15% | 1.96% | |
60 Neutral | £408.57M | 6.81 | 7.51% | 5.15% | -3.98% | 412.08% |